RecruitingNot applicableNCT03017573

Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE)

Studying Sarcoma of cervix uteri

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Institut Curie
Principal Investigator
Edith BORCOMAN, Prof.
Institut Curie
Intervention
Tumor biopsies / Tumor surgery(procedure)
Enrollment
1050 enrolled
Eligibility
18 years · All sexes
Timeline
2017 – 2032

Study locations (6)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03017573 on ClinicalTrials.gov

Other trials for Sarcoma of cervix uteri

Additional recruiting or active studies for the same condition.

See all trials for Sarcoma of cervix uteri →

← Back to all trials